Cibus, Inc. (CBUS)
1.72
+0.13
(+8.18%)
USD |
NASDAQ |
Dec 09, 16:00
1.72
0.00 (0.00%)
After-Hours: 18:16
Cibus Profit Margin (Quarterly): -3.95K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp. | -- |
| CEL-SCI Corp. | -- |
| AIM ImmunoTech, Inc. | -12.63K% |
| IGC Pharma, Inc. | -953.4% |
| NovaBay Pharmaceuticals, Inc. | -255.9% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -150.4% |
| Return on Assets | -36.44% |
| Return on Invested Capital | -38.49% |
| Gross Profit Margin (Quarterly) | -126.7% |
| Operating Margin (Quarterly) | -2.51K% |
| Return on Net Operating Assets | -39.70% |